Who is sponsoring NCT03907761?

NCT03907761 is sponsored by Ankara University.

What drugs are being tested in NCT03907761?

Interventions in NCT03907761: Hydrodissection.

What condition does NCT03907761 study?

NCT03907761 studies Recurrent Laryngeal Nerve Injuries.

Is NCT03907761 still recruiting?

NCT03907761 is currently completed. Last updated 9 April 2019.

Last reviewed 2019-04-09 · How we verify

NCT03907761

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hydrodissection of Recurrent Laryngeal Nerve: Case Series

Completed Last updated 9 April 2019

What this trial tests

trial testing Hydrodissection in Recurrent Laryngeal Nerve Injuries in 34 participants. Completed in 31 December 2018.

Timeline

1 February 2016

Primary endpoint
31 August 2017

31 December 2018

Quick facts

Lead sponsor	Ankara University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	34
Start date	1 February 2016
Primary completion	31 August 2017
Estimated completion	31 December 2018

Drugs / interventions tested

Hydrodissection

Conditions studied

Recurrent Laryngeal Nerve Injuries — all drugs for Recurrent Laryngeal Nerve Injuries →

Sponsor

Ankara University

Who can join

Adults 18 to 65, any sex, with Recurrent Laryngeal Nerve Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the hydrodissection technique in recurrent laryngeal nerve (RLN) dissection in thyroid surgeries. In this study hydrodissection of RLN was performed routinely in thyroid surgeries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Hydrodissection

Trials testing the same drug.

NCT03427983 — Hydrodissection as a Treatment for Carpal Tunnel Syndrome · NA · completed

Other recruiting trials for Recurrent Laryngeal Nerve Injuries

Currently open trials in the same condition.

NCT06406725 — Detection of Vocal Fold Motion Impairment on Noninvasive Positive Pressure · recruiting

Other Ankara University trials

Trials by the same sponsor.

NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03907761 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara University
Last refreshed: 9 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03907761.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing